Cozad Asset Management’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
Other funds holding EW
Cozad Asset Management's EW Position: Q2 2026 in Review
Cozad Asset Management opened a new position in Edwards Lifesciences (EW) in Q2 2026: 2,400 shares worth $217K. The stake represents 0.01% of the portfolio and ranks #433 among its holdings. This is a return to the name: Cozad Asset Management previously reported a position in EW as recently as Q4 2025.
Cozad Asset Management first reported a position in EW in Q3 2019 and has held it in 19 quarters since. The position peaked at $3.13M in Q4 2020. 1,333 funds tracked by Wall St. Rank hold EW as of Q2 2026.
- Cozad Asset Management held 2,400 shares of Edwards Lifesciences worth $217K as of Q2 2026.
- Edwards Lifesciences was a new Cozad Asset Management position in Q2 2026.
- Edwards Lifesciences made up 0.01% of Cozad Asset Management's portfolio in Q2 2026, its #433 holding.
- Cozad Asset Management first reported a position in Edwards Lifesciences in Q3 2019 and has held it in 19 quarters since.
- Cozad Asset Management's Edwards Lifesciences position peaked at $3.13M in Q4 2020.
- 1,333 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.
Based on Cozad Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.